Dr Simon Gollins
BMBCh DPhil MRCP FRCR
I have been a Consultant Clinical Oncologist based at the North Wales Cancer Treatment Centre since June 1998 and have been Clinical Director of Oncology for Betsi Cadwaladr University Health Board since 2010. As a Clinical Oncologist I am responsible for treating patients with cancer with both radiotherapy and chemotherapy and my subspecialty interests are upper and lower gastrointestinal cancer, pancreaticobiliary cancer, head and neck cancer and thyroid cancer.
I qualified in medicine in 1988 at the University of Oxford, where I also carried out 3 years of laboratory research for a Doctor of Philosophy degree (PhD). Following medical jobs in Bath and Birmingham I gained my Membership of the Royal College of Physicians in 1991. My oncology training took place at the Christie Hospital Manchester where I gained my Fellowship of the Royal College of Radiologists in 1994 and at Velindre Hospital Cardiff where I was also a Consultant Clinical Oncologist prior to moving to North Wales.
In my NHS practice I am responsible for regular outpatient clinics at the North Wales Cancer Treatment Centre and Wrexham Maelor Hospital.
For many years I have been very actively involved in clinical research related to my subspecialty interests and since 2005 I have been North Wales Clinical Lead for the Wales Cancer Research Network. Since 2008 I have been a Member of the Colorectal Clinical Studies Group of the National Cancer Research Institute (NCRI) and in October 2013 was appointed visiting Professor at Glyndwr University.
Some of the principal treatments carried out by Dr Simon Gollins at Spire include:
Visiting Professor, Glyndwr University
Consultant Clinical Oncologist and Clinical Director of Oncology within the Betsi Cadwaladr University Health Board
North Wales Clinical Lead for the Wales Cancer Research Network
National Institute for Social Care and Health Research Academic Health Science Collaboration (NISCHR AHSC) Clinical
Research Fellow, School of Medical Sciences, Bangor University
Member of the Colorectal Clinical Studies Group of the National Cancer Research Institute (NCRI)